CTRI/2021/07/034769尚未招募未知
Evaluation of new Ayurvedic formulations regime in moderate COVID 19 patients - Regime
Bonigi Anandaiah0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Moderate COVID- 19 confirmed participants of age > 18 years, both sexes and willing to participate with consent.
- •WHO definition of the moderate case- Pneumonia with no signs of severe disease-Adolescent or adult with the presence of clinical features of dyspnea and or hypoxia, fever, cough, including SpO2 <94%( range 90-94%) on room air, Respiratory Rate more or equal to 24 per minute.
排除标准
- •Those who are not willing to participate, patients with severe co- morbidities such as uncontrolled Diabetes, Liver disease, Renal disorders, uncontrolled Hypertension, pregnant and lactating women and severe COVID-19.
研究者
相似试验
尚未招募
2 期
Role of ayurvedic medicine in cancerCTRI/2022/09/045590Dr Rajeev Kumar
招募中
2 期
Ayurvedic study for the treatment of ObesityCTRI/2015/09/006150Central Council for Research in Ayurvedic Sciences
尚未招募
3 期
Impact of traditional ayurvedic drug Lipidom and Yoga Intervention vs Placebo in Dyslipidemia.CTRI/2022/11/046979Patanjali Research Institute governed by Patanjali Research Foundation Trust
已完成
2 期
Role of Triphaladi mouthwash in patients of dental caries.CTRI/2018/02/012165IPGT and RA40
进行中（未招募）
2 期
Clinical evaluation of Ayurvedic formulation in the Management of parikartika(Fissure in Ano)CTRI/2017/06/008773CCRASNew Delhi60